对p-tau217进行血液测试,可以预测早到25岁的妇女的痴呆症,根据哥伦比亚大学圣地亚哥分校的研究。 A blood test for p-tau217 may predict dementia in women up to 25 years early, per UC San Diego study.

根据加利福尼亚大学圣地亚哥大学的一项研究,测量p-tau217水平的新血液测试可以预测,在出现症状前25年的妇女中,可能会出现痴呆症。 A new blood test measuring p-tau217 levels may predict dementia in women up to 25 years before symptoms appear, according to a University of California San Diego study. 研究人员分析从2 766名妇女跟踪到25年的数据后发现,研究开始时的p-tau217水平较高,这与晚期痴呆症和轻度认知障碍密切相关,特别是70岁以上妇女、患APOE 4基因的妇女和雌激素加蛋白激素疗法的妇女。 Analyzing data from 2,766 women followed for up to 25 years, researchers found higher p-tau217 levels at the study’s start were strongly linked to later dementia and mild cognitive impairment, especially in women over 70, those with the APOE ε4 gene, and those on estrogen plus progestin hormone therapy. 与脑扫描或脊椎液测试相比,该测试的侵入性小于大脑扫描或脊椎液测试,为早期预防提供了潜力,尽管尚未建议临床使用该测试,需要在不同人群中进行进一步研究。 The test, less invasive than brain scans or spinal fluid tests, offers potential for early prevention, though it is not yet recommended for clinical use and requires further study across diverse populations.